Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXYTAHANE
2023-508413-16-00Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in alternating hemiplegia of childhood (AHC) comparing High-flow oxygen with Placebo (medical air) (2 arms). Primary endpoint: Proportion of motor attacks stopped within 30 minutes. Started Mar 2024; status: completed.
02
Drugs
oxygen
03
Conditions
alternating hemiplegia of childhood (AHC)
Beyond the preview
Go deeper on 2023-508413-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508413-16-00.